EP3324968
THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-GP INHIBITOR FOR THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.7.2016EP published:
27.9.2023EP application number:
16827318.3
EPO information:
European Patent Register
Max expiry date:
20.7.2036
Title in English:
THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-GP INHIBITOR FOR THE TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
21.7.2016EP application
27.9.2023EP Publication
Owner
Name:
Athenex Therapeutics LimitedAddress:
11/F Axa Center Gloucester Road, 151, Hong Kong, CN
Inventor
Name:
KWAN, Min-fun, RudolfAddress:
Summit, NJ 07901, US
Name:
KRAMER, E., DouglasAddress:
Stamford, CT 06905, US
Name:
FETTERLY, Geralk, J.Address:
Getezville, NY 14068, US
Name:
HUNG, Cheung-takAddress:
Dunedin 9010, NZ
Name:
JACKSON, Christopher Glyn Charles, AlexanderAddress:
Dunedin 9012, NZ
Name:
GLUE, Paul, WilliamAddress:
Dunedin 9054, NZ
Priority
Number:
201562195243 PDate:
21.7.2015Country:
US
Classification
Categories:
A61K 31/475, A61K 31/337, A61P 35/00, A61K 31/4725, A61P 35/02